AIXC
AIxCrypto Holdings, Inc.
Price Chart
Latest Quote
$1.72
Current Price| Previous Close | $1.77 |
| Open | $1.76 |
| Day High | $1.89 |
| Day Low | $1.72 |
| Volume | 76,909 |
Stock Information
| Total Debt | $3.24M |
| Cash Equivalents | $38.78M |
| Net Income | $-8.09M |
| Sector | Technology |
| Industry | Software - Infrastructure |
| P/E Ratio | 0.60 |
| EPS (TTM) | $2.86 |
| Exchange | NCM |
đ Custom Metrics & Score
Score: 11/42| Debt to Equity | 0.75 |
| Debt to Earnings | -0.33 |
| Current Ratio | 2.33 |
| Quick Ratio | 1.59 |
| Avg Revenue Growth | -25.00% |
| Return on Equity | -233.64% |
| Avg FCF Growth | -14.36% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $1.72 | 77,000 |
| 2026-01-30 | $1.77 | 87,900 |
| 2026-01-29 | $1.90 | 111,800 |
| 2026-01-28 | $2.08 | 108,500 |
| 2026-01-27 | $2.17 | 42,600 |
| 2026-01-26 | $2.14 | 40,900 |
| 2026-01-23 | $2.14 | 28,900 |
| 2026-01-22 | $2.14 | 60,400 |
| 2026-01-21 | $2.12 | 129,800 |
| 2026-01-20 | $2.33 | 78,000 |
| 2026-01-16 | $2.32 | 40,800 |
| 2026-01-15 | $2.36 | 63,100 |
| 2026-01-14 | $2.51 | 20,000 |
| 2026-01-13 | $2.47 | 70,800 |
| 2026-01-12 | $2.69 | 49,800 |
| 2026-01-09 | $2.56 | 53,000 |
| 2026-01-08 | $2.56 | 23,100 |
| 2026-01-07 | $2.69 | 56,500 |
| 2026-01-06 | $2.75 | 82,000 |
| 2026-01-05 | $2.65 | 117,500 |
About AIxCrypto Holdings, Inc.
AIxCrypto Holdings, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase I clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. The company was formerly known as Qualigen Therapeutics, Inc. and changed its name to AIxCrypto Holdings, Inc. in November 2025. The company was founded in 1996 and is based in Carlsbad, California.
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $5,653,725 |
| Operating Revenue | $0 | $0 | $0 | $5,653,725 |
| Reconciled Cost Of Revenue | - | - | $4,302,755 | $4,332,485 |
| Cost Of Revenue | - | - | $4,302,755 | $4,332,485 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $908,943 | $1,524,722 | $34,397 | - |
| Total Expenses | $5,401,720 | $11,304,857 | $14,760,720 | $28,316,761 |
| Other Income Expense | $29,011 | $349,776 | $907,203 | $4,728,633 |
| Other Non Operating Income Expenses | $-8,028 | $38,994 | $1,125 | $5,446 |
| Net Non Operating Interest Income Expense | $-780,148 | $-1,524,722 | $-34,397 | $42,693 |
| Interest Expense Non Operating | $908,943 | $1,524,722 | $34,397 | - |
| Operating Expense | $5,401,720 | $11,304,857 | $14,760,720 | $23,984,276 |
| General And Administrative Expense | $4,204,558 | $6,095,607 | $10,274,600 | $11,724,964 |
| Total Other Finance Cost | - | - | $26,646 | $-42,693 |
| Selling And Marketing Expense | - | - | $950,420 | $542,594 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-6,159,191 | $-12,131,972 | $-11,500,362 | $-17,897,137 |
| Net Interest Income | $-780,148 | $-1,524,722 | $-34,397 | $42,693 |
| Interest Income | $128,795 | - | - | - |
| Normalized Income | $-6,188,452 | $-12,442,630 | $-12,217,052 | $-21,345,064 |
| Net Income From Continuing And Discontinued Operation | $-6,259,191 | $-13,417,212 | $-18,640,543 | $-17,897,137 |
| Total Operating Income As Reported | $-5,761,720 | $-11,304,857 | $-14,760,720 | $-22,663,036 |
| Net Income Common Stockholders | $-6,346,795 | $-13,417,212 | $-18,640,543 | $-17,897,137 |
| Net Income | $-6,259,191 | $-13,417,212 | $-18,640,543 | $-17,897,137 |
| Net Income Including Noncontrolling Interests | $-6,259,191 | $-13,760,250 | $-21,034,643 | $-17,897,137 |
| Net Income Discontinuous Operations | $-100,000 | $-1,285,240 | $-7,140,181 | - |
| Net Income Continuous Operations | $-6,159,191 | $-12,475,010 | $-13,894,462 | $-17,897,137 |
| Pretax Income | $-6,152,857 | $-12,479,803 | $-13,887,914 | $-17,891,710 |
| Special Income Charges | $-569,839 | $-1,724,687 | $0 | $0 |
| Interest Income Non Operating | $128,795 | - | - | - |
| Operating Income | $-5,401,720 | $-11,304,857 | $-14,760,720 | $-22,663,036 |
| Gross Profit | - | - | $680,801 | $1,321,240 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $-17.55 | $-132.25 | $-243.00 | $-305.00 |
| Basic EPS | $-17.55 | $-132.25 | $-243.00 | $-305.00 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $7,778 | $124 | $190,513 | $1,275,260 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-5,280,953 | $-11,261,368 | $-14,748,555 | $-27,047,946 |
| Total Unusual Items | $37,039 | $310,782 | $907,203 | $4,723,187 |
| Total Unusual Items Excluding Goodwill | $37,039 | $310,782 | $907,203 | $4,723,187 |
| Reconciled Depreciation | $0 | $4,495 | $12,165 | $338,277 |
| EBITDA (Bullshit earnings) | $-5,243,914 | $-10,950,586 | $-13,841,352 | $-22,324,759 |
| EBIT | $-5,243,914 | $-10,955,081 | $-13,853,517 | $-22,663,036 |
| Diluted Average Shares | $361,587 | $101,454 | $76,806 | $58,669 |
| Basic Average Shares | $361,587 | $101,454 | $76,806 | $58,669 |
| Diluted NI Availto Com Stockholders | $-6,346,795 | $-13,417,212 | $-18,640,543 | $-17,897,137 |
| Otherunder Preferred Stock Dividend | $87,604 | $0 | - | - |
| Minority Interests | $0 | $343,038 | $2,394,100 | $0 |
| Tax Provision | $6,334 | $-4,793 | $6,548 | $5,427 |
| Gain On Sale Of Ppe | $0 | $-21,747 | $0 | - |
| Other Special Charges | $209,839 | $1,702,940 | - | - |
| Write Off | $360,000 | $0 | - | - |
| Gain On Sale Of Security | $606,878 | $2,035,469 | $907,203 | $4,723,187 |
| Research And Development | $1,197,162 | $5,209,250 | $4,486,120 | $11,716,718 |
| Selling General And Administration | $4,204,558 | $6,095,607 | $10,274,600 | $12,267,558 |
| Other Gand A | $4,204,558 | $6,095,607 | $10,274,600 | $11,724,964 |
| Impairment Of Capital Assets | - | - | $4,239,000 | $0 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $2,679,036 | $-2,103,557 | $7,235,709 | $16,393,544 |
| Total Assets | $4,686,519 | $2,033,248 | $19,083,491 | $22,835,705 |
| Total Non Current Assets | $2,000 | $866,481 | $8,262,953 | $2,039,309 |
| Other Non Current Assets | $2,000 | $450,000 | $8,236,711 | $18,334 |
| Non Current Prepaid Assets | $0 | $416,481 | - | - |
| Current Assets | $4,684,519 | $1,166,767 | $10,820,538 | $20,796,397 |
| Other Current Assets | $31,200 | $25,053 | $12,626 | $3,577 |
| Prepaid Assets | $1,468,019 | $739,911 | $1,366,704 | $1,376,319 |
| Receivables | $2,010,692 | $0 | $0 | $822,351 |
| Notes Receivable | $2,010,692 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $1,174,608 | $401,803 | $3,165,985 | $17,538,272 |
| Cash And Cash Equivalents | $1,174,608 | $401,803 | $3,165,985 | $17,538,272 |
| Assets Held For Sale Current | - | $0 | $6,287,849 | - |
| Cash Financial | - | $401,803 | $3,165,985 | $17,538,272 |
| Goodwill And Other Intangible Assets | - | - | $6,471,304 | $171,190 |
| Other Intangible Assets | - | - | $5,845,702 | $171,190 |
| Inventory | - | - | $1,586,297 | $1,055,878 |
| Accounts Receivable | - | - | $538,587 | $822,351 |
| Allowance For Doubtful Accounts Receivable | - | - | $-187,862 | $-136,097 |
| Gross Accounts Receivable | - | - | $726,449 | $958,448 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Debt | - | $897,413 | - | - |
| Total Debt | - | $1,299,216 | $60,197 | $1,676,655 |
| Current Debt And Capital Lease Obligation | - | $1,299,216 | $60,197 | $134,091 |
| Current Debt | - | $1,299,216 | $60,197 | - |
| Other Current Borrowings | - | $1,299,216 | $60,197 | - |
| Long Term Debt And Capital Lease Obligation | - | - | $1,301,919 | $1,542,564 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $2,007,483 | $4,136,805 | $10,316,901 | $6,270,971 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $1,708,732 | $1,635,492 |
| Current Liabilities | $2,007,483 | $4,136,805 | $8,608,169 | $4,635,479 |
| Other Current Liabilities | $269,175 | $54,600 | $7,063,845 | $1,686,200 |
| Payables And Accrued Expenses | $1,738,308 | $2,653,490 | $1,414,127 | $2,662,625 |
| Interest Payable | $0 | $10,004 | $2,829 | $0 |
| Payables | $1,568,065 | $2,222,983 | $619,568 | $903,934 |
| Accounts Payable | $1,568,065 | $2,222,983 | $619,568 | $886,224 |
| Liabilities Heldfor Sale Non Current | - | $0 | $1,708,732 | - |
| Non Current Deferred Liabilities | - | - | $406,813 | $92,928 |
| Non Current Deferred Taxes Liabilities | - | - | $357,757 | $0 |
| Current Deferred Liabilities | - | - | $116,161 | $135,063 |
| Current Notes Payable | - | - | $950,722 | $0 |
| Total Tax Payable | - | - | $32,194 | $17,710 |
| Income Tax Payable | - | - | $4,663 | $3,620 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $-3,037,364 | $-2,103,557 | $7,235,709 | $16,564,734 |
| Preferred Stock Equity | $5,716,400 | - | - | - |
| Total Equity Gross Minority Interest | $2,679,036 | $-2,103,557 | $8,766,590 | $16,564,734 |
| Stockholders Equity | $2,679,036 | $-2,103,557 | $7,235,709 | $16,564,734 |
| Retained Earnings | $-123,061,575 | $-116,802,384 | $-103,385,172 | $-84,744,629 |
| Gains Losses Not Affecting Retained Earnings | - | $0 | $50,721 | $0 |
| Other Equity Adjustments | - | - | $50,721 | - |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Ordinary Shares Number | $736,431 | $107,242 | $84,214 | $70,580 |
| Share Issued | $736,431 | $107,242 | $84,214 | $70,580 |
| Tangible Book Value | $-3,037,364 | $-2,103,557 | $7,235,709 | $16,393,544 |
| Invested Capital | $-3,037,364 | $-804,341 | $7,295,906 | $16,564,734 |
| Working Capital | $2,677,036 | $-2,970,038 | $2,212,369 | $16,160,918 |
| Total Capitalization | $2,679,036 | $-2,103,557 | $7,235,709 | $16,564,734 |
| Additional Paid In Capital | $119,958,897 | $114,655,565 | $110,528,050 | $101,274,073 |
| Capital Stock | $5,781,714 | $43,262 | $42,110 | $35,290 |
| Common Stock | $65,314 | $43,262 | $42,110 | $35,290 |
| Preferred Stock | $5,716,400 | $0 | - | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $0 | $129,499 | $70,000 | $17,500 |
| Current Accrued Expenses | $170,243 | $430,507 | $794,559 | $1,758,691 |
| Minority Interest | - | $0 | $1,530,881 | $0 |
| Net PPE | - | $0 | $26,242 | $1,849,785 |
| Capital Lease Obligations | - | - | $1,696,997 | $1,676,655 |
| Non Current Deferred Revenue | - | - | $49,056 | $92,928 |
| Long Term Capital Lease Obligation | - | - | $1,301,919 | $1,542,564 |
| Current Deferred Revenue | - | - | $116,161 | $135,063 |
| Current Capital Lease Obligation | - | - | $395,078 | $134,091 |
| Goodwill | - | - | $625,602 | $0 |
| Accumulated Depreciation | - | - | $-4,698,446 | $-4,541,238 |
| Gross PPE | - | - | $6,466,071 | $6,391,023 |
| Leases | - | - | $333,271 | $333,271 |
| Other Properties | - | - | $3,081,984 | $3,086,781 |
| Machinery Furniture Equipment | - | - | $3,050,816 | $2,970,971 |
| Properties | - | - | $0 | $0 |
| Finished Goods | - | - | $436,183 | $44,428 |
| Work In Process | - | - | $200,318 | $188,135 |
| Raw Materials | - | - | $949,796 | $823,315 |
| Construction In Progress | - | - | - | $0 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-6,327,503 | $-10,304,263 | $-13,247,541 | $-14,872,106 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $-6,327,503 | $-10,304,263 | $-13,247,541 | $-14,730,742 |
| Cash From Discontinued Operating Activities | $0 | $-1,210,664 | $-2,648,679 | - |
| Cash Flow From Continuing Operating Activities | $-6,327,503 | $-9,093,599 | $-10,598,862 | $-14,730,742 |
| Operating Gains Losses | $29,286 | $-1,380,124 | $-838,975 | $-4,424,536 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Investing Cash Flow | $-1,907,400 | $4,215,943 | $-183,763 | $-141,364 |
| Cash From Discontinued Investing Activities | $350,000 | $4,215,943 | $-183,763 | - |
| Cash Flow From Continuing Investing Activities | $-2,257,400 | $0 | $-183,763 | $-141,364 |
| Net Other Investing Changes | $-2,257,400 | - | - | - |
| Capital Expenditure | - | - | $-319,117 | $-141,364 |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Issuance Of Capital Stock | $7,615,749 | $0 | $0 | $8,820,000 |
| Financing Cash Flow | $9,007,708 | $-550,000 | $2,910,515 | $8,433,808 |
| Cash From Discontinued Financing Activities | $0 | $0 | $0 | - |
| Cash Flow From Continuing Financing Activities | $9,007,708 | $-550,000 | $2,910,515 | $8,433,808 |
| Net Other Financing Charges | $-499,021 | $1,210,664 | - | $-706,929 |
| Net Preferred Stock Issuance | $4,562,400 | $0 | - | $0 |
| Preferred Stock Issuance | $4,562,400 | $0 | - | $0 |
| Net Common Stock Issuance | $3,053,349 | $0 | $-505 | $8,820,000 |
| Common Stock Issuance | $3,053,349 | $0 | $0 | $8,820,000 |
| Repurchase Of Capital Stock | - | $0 | $-505 | $0 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repayment Of Debt | $-2,499,021 | $-550,000 | $0 | $-138,739 |
| Issuance Of Debt | $3,475,000 | $0 | $2,903,847 | $0 |
| Interest Paid Supplemental Data | $92,838 | $0 | $0 | $1,233 |
| Income Tax Paid Supplemental Data | $5,522 | $5,571 | $5,571 | $5,133 |
| End Cash Position | $1,174,608 | $401,803 | $3,165,985 | $17,538,272 |
| Beginning Cash Position | $401,803 | $7,040,123 | $17,538,273 | $23,976,570 |
| Changes In Cash | $772,805 | $-6,638,320 | $-10,520,789 | $-6,438,298 |
| Proceeds From Stock Option Exercised | $415,980 | $0 | $7,173 | $459,476 |
| Net Issuance Payments Of Debt | $975,979 | $-550,000 | $2,903,847 | $-138,739 |
| Net Short Term Debt Issuance | $975,979 | $-550,000 | $2,903,847 | $-138,739 |
| Short Term Debt Payments | $-2,499,021 | $-550,000 | $0 | $-138,739 |
| Short Term Debt Issuance | $3,475,000 | $0 | $2,903,847 | $0 |
| Net Investment Purchase And Sale | $-2,257,400 | $0 | - | - |
| Purchase Of Investment | $-2,257,400 | $0 | - | - |
| Change In Working Capital | $-783,584 | $1,111,580 | $-642,866 | $2,213,236 |
| Change In Payables And Accrued Expense | $-563,810 | $1,376,321 | $-515,881 | $1,432,618 |
| Change In Accrued Expense | $-118,669 | $-227,101 | $-472,441 | $1,047,163 |
| Change In Payable | $-445,141 | $1,603,422 | $-43,440 | $385,455 |
| Change In Account Payable | $-445,141 | $1,603,422 | $-43,440 | $385,455 |
| Change In Prepaid Assets | $-219,774 | $-264,741 | $-126,985 | $1,298,998 |
| Other Non Cash Items | $97,927 | $2,546,927 | - | $101,750 |
| Stock Based Compensation | $128,059 | $1,098,533 | $4,765,276 | $5,293,651 |
| Provisionand Write Offof Assets | $360,000 | $0 | $-41,039 | $-355,983 |
| Depreciation Amortization Depletion | $0 | $4,495 | $12,165 | $338,277 |
| Depreciation And Amortization | $0 | $4,495 | $12,165 | $338,277 |
| Gain Loss On Investment Securities | $-236,563 | $-2,027,524 | $-838,975 | $-4,424,536 |
| Gain Loss On Sale Of PPE | $0 | $21,747 | $0 | - |
| Net Income From Continuing Operations | $-6,159,191 | $-12,475,010 | $-13,894,462 | $-17,897,137 |
| Other Cash Adjustment Outside Changein Cash | - | $0 | $-3,874,138 | - |
| Effect Of Exchange Rate Changes | - | $0 | $22,639 | $0 |
| Common Stock Payments | - | $0 | $-505 | $0 |
| Net Business Purchase And Sale | - | - | $135,354 | $0 |
| Sale Of Business | - | - | $135,354 | $0 |
| Net Intangibles Purchase And Sale | - | - | $0 | $-6,893 |
| Purchase Of Intangibles | - | - | $0 | $-6,893 |
| Net PPE Purchase And Sale | - | - | $-319,117 | $-134,471 |
| Purchase Of PPE | - | - | $-319,117 | $-134,471 |
| Change In Other Working Capital | - | - | $-334,397 | $-416,312 |
| Change In Other Current Liabilities | - | - | $-668,517 | $-254,740 |
| Change In Inventory | - | - | $-637,410 | $111,422 |
| Change In Receivables | - | - | $417,708 | $41,250 |
| Changes In Account Receivables | - | - | $417,708 | $41,250 |
| Asset Impairment Charge | - | - | $4,239,000 | $0 |
| Depreciation | - | - | $375,603 | $338,277 |
| Net Long Term Debt Issuance | - | - | - | $0 |
| Long Term Debt Payments | - | - | - | $-138,739 |
| Long Term Debt Issuance | - | - | - | $0 |